COVID-19 (Coronavirus) is a PANDEMIC with no immediate vaccines, treatments and widespread diagnostics
available. The USA and World health providers, pharmaceutical companies and governments are actively
working to fund these vital initiatives. “Social distancing” with its associated shutdown of
commerce and normal routine appears to be the best solution so far in PREVENTING the spread of the COVID
virus and associated suffering and mortality. The loss of life once a patient goes on a ventilator is
frightening.
As the administration and American leaders have stated, that “economic shutdown” and “repeat of a shutdown”,
cannot endure. Advanced Penetration Technology, LLC strongly believes the proprietary APT™ based
NON-PRESCRIPTION (OTC) Topical formulation, used off-label, will play an important role in mitigating,
decreasing and preventing the spread and severity of COVID-19 illness.
The Advanced Penetration Technology, LLC recommends the use of APT™ T3X formulation as a tool to mitigate the
COVID-19 virus based upon recent and ongoing anti-viral studies.
Recently concluded Anti-Viral Studies demonstrated the significant efficacy of the APT™ T3X formulation in
neutralizing the Influenza A virus (H1N1) and Coronavirus (NL63). The laboratory conclusion
was “Under the conditions tested, treatment of influenza A/WSN/33 virus and
Coronavirus NL63, with APT™ T3X formulation abolishes infectivity”. Further USA based viral
testing is ongoing. PFTH, LLC believes APT™ T3X formulation will neutralize infectivity of all
viruses.
Decreasing the Viral Load of Exposure is the key to slowing and mitigating the
spread of COVID-19 virus. The daily use of APT™ T3X formulation as a nasal swab application will help in
the mitigation of the COVID-19 Pandemic.
- Application recommendations for Healthcare Workers, Military personnel, First Responders, (at) High risk
individuals and the General Public: Swabbing the formulation within each nasal cavity every 12
hours could reduce the exposure levels of the COVID-19 virus into the body, hence reducing infectivity of
the individual and decrease transmission to others.
- Application recommendations for Non-symptomatic COVID-19 patients: Swabbing the product within the
nasal cavity every 12 hours to mitigate infectivity, transmission and progression of the disease.
- APT™ T3X formulation use along with recommended CDC guidelines for COVID-19 prevention, together, create
another barrier to infection and transmission to fight this Pandemic.
Using ATP™ T3X and reasonable CDC guidelines, Grandparents should be able to hug their grandchildren,
Worshipers should be able to attend church services, Students should be able to get back into schools
and colleges, and the lifeblood of the US, our Economy, should keep moving forward.
Buy Now
